Focus
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Focus 4:327-338, Summer 2006
© 2006 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* CME: Take the course for this article:
Genetics and Psychiatry
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by Kempf, L.
* Articles by Meyer-Lindenberg, A.
* Search for Related Content
PubMed
* Articles by Kempf, L.
* Articles by Meyer-Lindenberg, A.

CLINICAL SYNTHESIS

Imaging Genetics and Psychiatry

Lucas Kempf, M.D., and Andreas Meyer-Lindenberg, M.D., Ph.D.

Correspondence: Address correspondence to Andreas Meyer-Lindenberg, M.D., Ph.D., 10-3C103, 9000 Rockville Pike, Bethesda, MD 20892–1365; e-mail, andreasml{at}nih.gov.

Many important psychiatric disorders have a strong hereditary component, posing the problem of characterizing the biological mechanisms translating from the genetic level to that of complex social and behavioral abnormalities. The new field of imaging genetics uses neuroimaging methods to assess the impact of genetic variation on the human brain. Ideally, several imaging methods are used in conjunction to achieve an optimal characterization of structural-functional parameters in large groups of carefully screened individuals, whose genotype is then statistically related to these data across subjects. Imaging genetics is therefore a form of genetic association study. Although this approach is still relatively novel, the emerging literature shows that it can be used to identify neural processes involved in mediating the effect of genetic polymorphisms on psychiatric disease risk, contributing to the understanding of the pathophysiology of these complex disorders. We illustrate this approach using selected examples from genes involved in risk for schizophrenia (COMT, GRM3, DISC1, and G72), Alzheimer’s disease (APOE4), and depression, anxiety, and violence (5-HTTLPR and MAOA). Improved mechanistic understanding of psychiatric disease provides novel targets for future therapeutic interventions and may contribute to a more accurate biologically based nosology.







Get information about faster international access.

Privacy Policy

Copyright © 2006 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org